#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Carotenoids are a group of natural pigments , consisting of more than 750 compounds known so far .
1-1	0-11	Carotenoids	substance	new	coref	3-13[10_0]
1-2	12-15	are	_	_	_	_
1-3	16-17	a	abstract[2]	new[2]	ana	2-1[0_2]
1-4	18-23	group	abstract[2]	new[2]	_	_
1-5	24-26	of	abstract[2]	new[2]	_	_
1-6	27-34	natural	abstract[2]	new[2]	_	_
1-7	35-43	pigments	abstract[2]	new[2]	_	_
1-8	44-45	,	_	_	_	_
1-9	46-56	consisting	_	_	_	_
1-10	57-59	of	_	_	_	_
1-11	60-64	more	substance[3]	new[3]	coref	5-2[21_3]
1-12	65-69	than	substance[3]	new[3]	_	_
1-13	70-73	750	substance[3]	new[3]	_	_
1-14	74-83	compounds	substance[3]	new[3]	_	_
1-15	84-89	known	substance[3]	new[3]	_	_
1-16	90-92	so	substance[3]	new[3]	_	_
1-17	93-96	far	substance[3]	new[3]	_	_
1-18	97-98	.	_	_	_	_

#Text=Their colours are mostly yellow , orange , or red due to the system of conjugated double bonds .
2-1	99-104	Their	abstract|abstract[5]	giv|new[5]	_	_
2-2	105-112	colours	abstract[5]	new[5]	_	_
2-3	113-116	are	_	_	_	_
2-4	117-123	mostly	_	_	_	_
2-5	124-130	yellow	_	_	_	_
2-6	131-132	,	_	_	_	_
2-7	133-139	orange	_	_	_	_
2-8	140-141	,	_	_	_	_
2-9	142-144	or	_	_	_	_
2-10	145-148	red	_	_	_	_
2-11	149-152	due	_	_	_	_
2-12	153-155	to	_	_	_	_
2-13	156-159	the	abstract[6]	new[6]	_	_
2-14	160-166	system	abstract[6]	new[6]	_	_
2-15	167-169	of	abstract[6]	new[6]	_	_
2-16	170-180	conjugated	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-17	181-187	double	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-18	188-193	bonds	abstract[6]|abstract[7]	new[6]|new[7]	_	_
2-19	194-195	.	_	_	_	_

#Text=This structural element is also responsible for the good antioxidant properties of many carotenoids .
3-1	196-200	This	substance[8]	new[8]	_	_
3-2	201-211	structural	substance[8]	new[8]	_	_
3-3	212-219	element	substance[8]	new[8]	_	_
3-4	220-222	is	_	_	_	_
3-5	223-227	also	_	_	_	_
3-6	228-239	responsible	_	_	_	_
3-7	240-243	for	_	_	_	_
3-8	244-247	the	abstract[9]	new[9]	_	_
3-9	248-252	good	abstract[9]	new[9]	_	_
3-10	253-264	antioxidant	abstract[9]	new[9]	_	_
3-11	265-275	properties	abstract[9]	new[9]	_	_
3-12	276-278	of	abstract[9]	new[9]	_	_
3-13	279-283	many	abstract[9]|substance[10]	new[9]|giv[10]	coref	4-1[0_10]
3-14	284-295	carotenoids	abstract[9]|substance[10]	new[9]|giv[10]	_	_
3-15	296-297	.	_	_	_	_

#Text=Carotenoids have shown numerous biological activities ( not only as provitamin A ) , making them an interesting topic for researchers of various disciplines all over the world looking for , e.g. , preventive properties of fruits and vegetables .
4-1	298-309	Carotenoids	substance	giv	coref	6-20
4-2	310-314	have	_	_	_	_
4-3	315-320	shown	_	_	_	_
4-4	321-329	numerous	abstract[12]	new[12]	ana	4-16[0_12]
4-5	330-340	biological	abstract[12]	new[12]	_	_
4-6	341-351	activities	abstract[12]	new[12]	_	_
4-7	352-353	(	_	_	_	_
4-8	354-357	not	_	_	_	_
4-9	358-362	only	place[13]	new[13]	_	_
4-10	363-365	as	place[13]	new[13]	_	_
4-11	366-376	provitamin	place[13]	new[13]	_	_
4-12	377-378	A	place[13]	new[13]	_	_
4-13	379-380	)	_	_	_	_
4-14	381-382	,	_	_	_	_
4-15	383-389	making	_	_	_	_
4-16	390-394	them	abstract	giv	coref	11-5[70_0]
4-17	395-397	an	_	_	_	_
4-18	398-409	interesting	_	_	_	_
4-19	410-415	topic	_	_	_	_
4-20	416-419	for	_	_	_	_
4-21	420-431	researchers	person[15]	new[15]	_	_
4-22	432-434	of	person[15]	new[15]	_	_
4-23	435-442	various	person[15]|abstract[16]	new[15]|new[16]	_	_
4-24	443-454	disciplines	person[15]|abstract[16]	new[15]|new[16]	_	_
4-25	455-458	all	person[15]|abstract[16]|place[17]	new[15]|new[16]|new[17]	_	_
4-26	459-463	over	person[15]|abstract[16]|place[17]	new[15]|new[16]|new[17]	_	_
4-27	464-467	the	person[15]|abstract[16]|place[17]	new[15]|new[16]|new[17]	_	_
4-28	468-473	world	person[15]|abstract[16]|place[17]	new[15]|new[16]|new[17]	_	_
4-29	474-481	looking	person[15]	new[15]	_	_
4-30	482-485	for	person[15]	new[15]	_	_
4-31	486-487	,	person[15]	new[15]	_	_
4-32	488-492	e.g.	person[15]|abstract[18]	new[15]|new[18]	coref	22-10[137_18]
4-33	493-494	,	person[15]|abstract[18]	new[15]|new[18]	_	_
4-34	495-505	preventive	person[15]|abstract[18]	new[15]|new[18]	_	_
4-35	506-516	properties	person[15]|abstract[18]	new[15]|new[18]	_	_
4-36	517-519	of	person[15]|abstract[18]	new[15]|new[18]	_	_
4-37	520-526	fruits	person[15]|abstract[18]|plant	new[15]|new[18]|new	_	_
4-38	527-530	and	person[15]|abstract[18]	new[15]|new[18]	_	_
4-39	531-541	vegetables	person[15]|abstract[18]|substance	new[15]|new[18]|new	_	_
4-40	542-543	.	_	_	_	_

#Text=As lipophilic compounds , their uptake and storage in the body are dependent on various conditions .
5-1	544-546	As	_	_	_	_
5-2	547-557	lipophilic	substance[21]	giv[21]	ana	5-5[0_21]
5-3	558-567	compounds	substance[21]	giv[21]	_	_
5-4	568-569	,	_	_	_	_
5-5	570-575	their	substance|abstract[23]	giv|new[23]	coref	6-13[32_0]
5-6	576-582	uptake	abstract[23]	new[23]	_	_
5-7	583-586	and	_	_	_	_
5-8	587-594	storage	place[24]	new[24]	_	_
5-9	595-597	in	place[24]	new[24]	_	_
5-10	598-601	the	place[24]|object[25]	new[24]|new[25]	_	_
5-11	602-606	body	place[24]|object[25]	new[24]|new[25]	_	_
5-12	607-610	are	_	_	_	_
5-13	611-620	dependent	_	_	_	_
5-14	621-623	on	_	_	_	_
5-15	624-631	various	abstract[26]	new[26]	_	_
5-16	632-642	conditions	abstract[26]	new[26]	_	_
5-17	643-644	.	_	_	_	_

#Text=In vitro and in vivo data showed stimulating and inhibitory effects of matrix compounds on bioaccessibility and bioavailability of carotenoids .
6-1	645-647	In	_	_	_	_
6-2	648-653	vitro	organization	new	coref	26-2
6-3	654-657	and	_	_	_	_
6-4	658-660	in	abstract[28]	new[28]	_	_
6-5	661-665	vivo	abstract[28]	new[28]	_	_
6-6	666-670	data	abstract	new	_	_
6-7	671-677	showed	_	_	_	_
6-8	678-689	stimulating	abstract[30]	new[30]	_	_
6-9	690-693	and	abstract[30]	new[30]	_	_
6-10	694-704	inhibitory	abstract[30]	new[30]	_	_
6-11	705-712	effects	abstract[30]	new[30]	_	_
6-12	713-715	of	abstract[30]	new[30]	_	_
6-13	716-722	matrix	abstract[30]|abstract|substance[32]	new[30]|new|giv[32]	_	_
6-14	723-732	compounds	abstract[30]|substance[32]	new[30]|giv[32]	_	_
6-15	733-735	on	abstract[30]	new[30]	_	_
6-16	736-752	bioaccessibility	abstract[30]|abstract|abstract[34]	new[30]|new|new[34]	ana	7-5[38_34]
6-17	753-756	and	abstract[30]|abstract[34]	new[30]|new[34]	_	_
6-18	757-772	bioavailability	abstract[30]|abstract[34]|abstract[35]	new[30]|new[34]|new[35]	_	_
6-19	773-775	of	abstract[30]|abstract[34]|abstract[35]	new[30]|new[34]|new[35]	_	_
6-20	776-787	carotenoids	abstract[30]|abstract[34]|abstract[35]|substance	new[30]|new[34]|new[35]|giv	coref	13-6
6-21	788-789	.	_	_	_	_

#Text=This special issue highlights some of the recent advances in carotenoid research , showing on the one hand the status quo and giving on the other hand new insight in functions and physiological relevance .
7-1	790-794	This	abstract[37]	new[37]	_	_
7-2	795-802	special	abstract[37]	new[37]	_	_
7-3	803-808	issue	abstract[37]	new[37]	_	_
7-4	809-819	highlights	_	_	_	_
7-5	820-824	some	abstract[38]	giv[38]	_	_
7-6	825-827	of	abstract[38]	giv[38]	_	_
7-7	828-831	the	abstract[38]|abstract[39]	giv[38]|new[39]	_	_
7-8	832-838	recent	abstract[38]|abstract[39]	giv[38]|new[39]	_	_
7-9	839-847	advances	abstract[38]|abstract[39]	giv[38]|new[39]	_	_
7-10	848-850	in	abstract[38]|abstract[39]	giv[38]|new[39]	_	_
7-11	851-861	carotenoid	abstract[38]|abstract[39]|object|abstract[41]	giv[38]|new[39]|new|new[41]	coref	23-14
7-12	862-870	research	abstract[38]|abstract[39]|abstract[41]	giv[38]|new[39]|new[41]	_	_
7-13	871-872	,	_	_	_	_
7-14	873-880	showing	_	_	_	_
7-15	881-883	on	_	_	_	_
7-16	884-887	the	_	_	_	_
7-17	888-891	one	_	_	_	_
7-18	892-896	hand	_	_	_	_
7-19	897-900	the	abstract[42]	new[42]	_	_
7-20	901-907	status	abstract[42]	new[42]	_	_
7-21	908-911	quo	abstract[42]	new[42]	_	_
7-22	912-915	and	_	_	_	_
7-23	916-922	giving	_	_	_	_
7-24	923-925	on	_	_	_	_
7-25	926-929	the	_	_	_	_
7-26	930-935	other	_	_	_	_
7-27	936-940	hand	_	_	_	_
7-28	941-944	new	abstract[43]	new[43]	_	_
7-29	945-952	insight	abstract[43]	new[43]	_	_
7-30	953-955	in	abstract[43]	new[43]	_	_
7-31	956-965	functions	abstract[43]|abstract	new[43]|new	_	_
7-32	966-969	and	abstract[43]	new[43]	_	_
7-33	970-983	physiological	abstract[43]|abstract[45]	new[43]|new[45]	_	_
7-34	984-993	relevance	abstract[43]|abstract[45]	new[43]|new[45]	_	_
7-35	994-995	.	_	_	_	_

#Text=Al-Yafeai et al. investigated rosehips of Rosa rugosa at different degrees of ripeness and showed that maturity stage significantly affected contents of bioactive ingredients as well as antioxidant capacity .
8-1	996-1005	Al-Yafeai	person	new	_	_
8-2	1006-1008	et	_	_	_	_
8-3	1009-1012	al.	_	_	_	_
8-4	1013-1025	investigated	_	_	_	_
8-5	1026-1034	rosehips	plant[47]	new[47]	_	_
8-6	1035-1037	of	plant[47]	new[47]	_	_
8-7	1038-1042	Rosa	plant[47]|person[48]	new[47]|new[48]	_	_
8-8	1043-1049	rugosa	plant[47]|person[48]	new[47]|new[48]	_	_
8-9	1050-1052	at	_	_	_	_
8-10	1053-1062	different	abstract[49]	new[49]	_	_
8-11	1063-1070	degrees	abstract[49]	new[49]	_	_
8-12	1071-1073	of	abstract[49]	new[49]	_	_
8-13	1074-1082	ripeness	abstract[49]|abstract	new[49]|new	_	_
8-14	1083-1086	and	_	_	_	_
8-15	1087-1093	showed	_	_	_	_
8-16	1094-1098	that	_	_	_	_
8-17	1099-1107	maturity	abstract|abstract[52]	new|new[52]	coref	27-5[161_52]
8-18	1108-1113	stage	abstract[52]	new[52]	_	_
8-19	1114-1127	significantly	_	_	_	_
8-20	1128-1136	affected	_	_	_	_
8-21	1137-1145	contents	substance[53]	new[53]	_	_
8-22	1146-1148	of	substance[53]	new[53]	_	_
8-23	1149-1158	bioactive	substance[53]|substance[54]	new[53]|new[54]	_	_
8-24	1159-1170	ingredients	substance[53]|substance[54]	new[53]|new[54]	_	_
8-25	1171-1173	as	substance[53]	new[53]	_	_
8-26	1174-1178	well	substance[53]	new[53]	_	_
8-27	1179-1181	as	substance[53]	new[53]	_	_
8-28	1182-1193	antioxidant	substance[53]|abstract[55]	new[53]|new[55]	_	_
8-29	1194-1202	capacity	substance[53]|abstract[55]	new[53]|new[55]	_	_
8-30	1203-1204	.	_	_	_	_

#Text=Thus , harvesting date can be chosen depending on the contents of bioactive molecules .
9-1	1205-1209	Thus	_	_	_	_
9-2	1210-1211	,	_	_	_	_
9-3	1212-1222	harvesting	event|time[57]	new|new[57]	_	_
9-4	1223-1227	date	time[57]	new[57]	_	_
9-5	1228-1231	can	_	_	_	_
9-6	1232-1234	be	_	_	_	_
9-7	1235-1241	chosen	_	_	_	_
9-8	1242-1251	depending	_	_	_	_
9-9	1252-1254	on	_	_	_	_
9-10	1255-1258	the	substance[58]	new[58]	coref	27-15[165_58]
9-11	1259-1267	contents	substance[58]	new[58]	_	_
9-12	1268-1270	of	substance[58]	new[58]	_	_
9-13	1271-1280	bioactive	substance[58]|substance[59]	new[58]|new[59]	coref	14-1[84_59]
9-14	1281-1290	molecules	substance[58]|substance[59]	new[58]|new[59]	_	_
9-15	1291-1292	.	_	_	_	_

#Text=In addition , the authors fully characterized ( 5’Z ) -rubixanthin ( gazaniaxanthin ) as the main ( Z )-isomer of rubixanthin in hips of R. rugosa by using HPLC-MS/MS and NMR .
10-1	1293-1295	In	_	_	_	_
10-2	1296-1304	addition	_	_	_	_
10-3	1305-1306	,	_	_	_	_
10-4	1307-1310	the	person[60]	new[60]	ana	12-1[0_60]
10-5	1311-1318	authors	person[60]	new[60]	_	_
10-6	1319-1324	fully	_	_	_	_
10-7	1325-1338	characterized	_	_	_	_
10-8	1339-1340	(	_	_	_	_
10-9	1341-1344	5’Z	_	_	_	_
10-10	1345-1346	)	_	_	_	_
10-11	1347-1359	-rubixanthin	_	_	_	_
10-12	1360-1361	(	_	_	_	_
10-13	1362-1376	gazaniaxanthin	plant	new	_	_
10-14	1377-1378	)	_	_	_	_
10-15	1379-1381	as	_	_	_	_
10-16	1382-1385	the	_	_	_	_
10-17	1386-1390	main	_	_	_	_
10-18	1391-1392	(	_	_	_	_
10-19	1393-1394	Z	person	new	_	_
10-20	1395-1403	)-isomer	_	_	_	_
10-21	1404-1406	of	_	_	_	_
10-22	1407-1418	rubixanthin	organization	new	_	_
10-23	1419-1421	in	_	_	_	_
10-24	1422-1426	hips	object[64]	new[64]	_	_
10-25	1427-1429	of	object[64]	new[64]	_	_
10-26	1430-1432	R.	object[64]|person|object[66]	new[64]|new|new[66]	_	_
10-27	1433-1439	rugosa	object[64]|object[66]	new[64]|new[66]	_	_
10-28	1440-1442	by	_	_	_	_
10-29	1443-1448	using	_	_	_	_
10-30	1449-1459	HPLC-MS/MS	abstract	new	_	_
10-31	1460-1463	and	_	_	_	_
10-32	1464-1467	NMR	abstract	new	_	_
10-33	1468-1469	.	_	_	_	_

#Text=Chitong et al. investigated biological activities of astaxanthin extracted from shrimp waste .
11-1	1470-1477	Chitong	person	new	_	_
11-2	1478-1480	et	_	_	_	_
11-3	1481-1484	al.	_	_	_	_
11-4	1485-1497	investigated	_	_	_	_
11-5	1498-1508	biological	abstract[70]	giv[70]	_	_
11-6	1509-1519	activities	abstract[70]	giv[70]	_	_
11-7	1520-1522	of	abstract[70]	giv[70]	_	_
11-8	1523-1534	astaxanthin	abstract[70]|substance[71]	giv[70]|new[71]	_	_
11-9	1535-1544	extracted	abstract[70]|substance[71]	giv[70]|new[71]	_	_
11-10	1545-1549	from	abstract[70]|substance[71]	giv[70]|new[71]	_	_
11-11	1550-1556	shrimp	abstract[70]|substance[71]|substance|substance[73]	giv[70]|new[71]|new|new[73]	_	_
11-12	1557-1562	waste	abstract[70]|substance[71]|substance[73]	giv[70]|new[71]|new[73]	_	_
11-13	1563-1564	.	_	_	_	_

#Text=They discussed a possible use of this extract in dietary supplements for skin health applications .
12-1	1565-1569	They	person	giv	coref	19-1[113_0]
12-2	1570-1579	discussed	_	_	_	_
12-3	1580-1581	a	abstract[75]	new[75]	_	_
12-4	1582-1590	possible	abstract[75]	new[75]	_	_
12-5	1591-1594	use	abstract[75]	new[75]	_	_
12-6	1595-1597	of	abstract[75]	new[75]	_	_
12-7	1598-1602	this	abstract[75]|substance[76]	new[75]|new[76]	_	_
12-8	1603-1610	extract	abstract[75]|substance[76]	new[75]|new[76]	_	_
12-9	1611-1613	in	abstract[75]	new[75]	_	_
12-10	1614-1621	dietary	abstract[75]|substance[77]	new[75]|new[77]	_	_
12-11	1622-1633	supplements	abstract[75]|substance[77]	new[75]|new[77]	_	_
12-12	1634-1637	for	abstract[75]|substance[77]	new[75]|new[77]	_	_
12-13	1638-1642	skin	abstract[75]|substance[77]|object|abstract[79]|abstract[80]	new[75]|new[77]|new|new[79]|new[80]	coref|coref	18-20[112_79]|24-11
12-14	1643-1649	health	abstract[75]|substance[77]|abstract[79]|abstract[80]	new[75]|new[77]|new[79]|new[80]	_	_
12-15	1650-1662	applications	abstract[75]|substance[77]|abstract[80]	new[75]|new[77]|new[80]	_	_
12-16	1663-1664	.	_	_	_	_

#Text=Apocarotenoids are cleavage products of carotenoids .
13-1	1665-1679	Apocarotenoids	substance	new	coref	13-3[82_0]
13-2	1680-1683	are	_	_	_	_
13-3	1684-1692	cleavage	substance[82]	giv[82]	coref	15-12[89_82]
13-4	1693-1701	products	substance[82]	giv[82]	_	_
13-5	1702-1704	of	substance[82]	giv[82]	_	_
13-6	1705-1716	carotenoids	substance[82]|substance	giv[82]|giv	coref	16-14
13-7	1717-1718	.	_	_	_	_

#Text=These molecules often showed biological activity .
14-1	1719-1724	These	substance[84]	giv[84]	_	_
14-2	1725-1734	molecules	substance[84]	giv[84]	_	_
14-3	1735-1740	often	_	_	_	_
14-4	1741-1747	showed	_	_	_	_
14-5	1748-1758	biological	abstract[85]	new[85]	coref	23-10[142_85]
14-6	1759-1767	activity	abstract[85]	new[85]	_	_
14-7	1768-1769	.	_	_	_	_

#Text=Thus , Zoccali et al. extracted four microalgae strains and characterized the apocarotenoids therein .
15-1	1770-1774	Thus	_	_	_	_
15-2	1775-1776	,	_	_	_	_
15-3	1777-1784	Zoccali	person	new	_	_
15-4	1785-1787	et	_	_	_	_
15-5	1788-1791	al.	_	_	_	_
15-6	1792-1801	extracted	_	_	_	_
15-7	1802-1806	four	abstract[88]	new[88]	_	_
15-8	1807-1817	microalgae	animal|abstract[88]	new|new[88]	_	_
15-9	1818-1825	strains	abstract[88]	new[88]	_	_
15-10	1826-1829	and	_	_	_	_
15-11	1830-1843	characterized	_	_	_	_
15-12	1844-1847	the	substance[89]	giv[89]	_	_
15-13	1848-1862	apocarotenoids	substance[89]	giv[89]	_	_
15-14	1863-1870	therein	_	_	_	_
15-15	1871-1872	.	_	_	_	_

#Text=Sandmann reviews structure dependence of antioxidant protection from UV and light stress by carotenoids .
16-1	1873-1881	Sandmann	person	new	_	_
16-2	1882-1889	reviews	abstract	new	coref|none	18-1[105_0]|16-2[0_105]
16-3	1890-1899	structure	abstract|abstract[92]	new|new[92]	_	_
16-4	1900-1910	dependence	abstract[92]	new[92]	_	_
16-5	1911-1913	of	abstract[92]	new[92]	_	_
16-6	1914-1925	antioxidant	abstract[92]|abstract[93]	new[92]|new[93]	_	_
16-7	1926-1936	protection	abstract[92]|abstract[93]	new[92]|new[93]	_	_
16-8	1937-1941	from	abstract[92]|abstract[93]	new[92]|new[93]	_	_
16-9	1942-1944	UV	abstract[92]|abstract[93]|substance|abstract[96]	new[92]|new[93]|new|new[96]	_	_
16-10	1945-1948	and	abstract[92]|abstract[93]|abstract[96]	new[92]|new[93]|new[96]	_	_
16-11	1949-1954	light	abstract[92]|abstract[93]|abstract|abstract[96]	new[92]|new[93]|new|new[96]	_	_
16-12	1955-1961	stress	abstract[92]|abstract[93]|abstract[96]	new[92]|new[93]|new[96]	_	_
16-13	1962-1964	by	abstract[92]	new[92]	_	_
16-14	1965-1976	carotenoids	abstract[92]|substance	new[92]|giv	coref	18-15
16-15	1977-1978	.	_	_	_	_

#Text=Substitutions at the hydrocarbon molecule are important for good singlet oxygen quenching and radical scavenging .
17-1	1979-1992	Substitutions	abstract[98]	new[98]	_	_
17-2	1993-1995	at	abstract[98]	new[98]	_	_
17-3	1996-1999	the	abstract[98]|substance[100]	new[98]|new[100]	_	_
17-4	2000-2011	hydrocarbon	abstract[98]|substance|substance[100]	new[98]|new|new[100]	_	_
17-5	2012-2020	molecule	abstract[98]|substance[100]	new[98]|new[100]	_	_
17-6	2021-2024	are	_	_	_	_
17-7	2025-2034	important	_	_	_	_
17-8	2035-2038	for	_	_	_	_
17-9	2039-2043	good	substance[103]	new[103]	_	_
17-10	2044-2051	singlet	object|substance[103]	new|new[103]	_	_
17-11	2052-2058	oxygen	substance|substance[103]	new|new[103]	_	_
17-12	2059-2068	quenching	substance[103]	new[103]	_	_
17-13	2069-2072	and	_	_	_	_
17-14	2073-2080	radical	event[104]	new[104]	_	_
17-15	2081-2091	scavenging	event[104]	new[104]	_	_
17-16	2092-2093	.	_	_	_	_

#Text=The review by Elvira-Torales et al. gives an overview on beneficial health-related effects of carotenoids with special emphasis on liver health .
18-1	2094-2097	The	abstract[105]	new[105]	_	_
18-2	2098-2104	review	abstract[105]	new[105]	_	_
18-3	2105-2107	by	abstract[105]	new[105]	_	_
18-4	2108-2122	Elvira-Torales	abstract[105]|person	new[105]|new	_	_
18-5	2123-2125	et	abstract[105]	new[105]	_	_
18-6	2126-2129	al.	abstract[105]	new[105]	_	_
18-7	2130-2135	gives	_	_	_	_
18-8	2136-2138	an	abstract[107]	new[107]	_	_
18-9	2139-2147	overview	abstract[107]	new[107]	_	_
18-10	2148-2150	on	abstract[107]	new[107]	_	_
18-11	2151-2161	beneficial	abstract[107]|abstract[108]	new[107]|new[108]	_	_
18-12	2162-2176	health-related	abstract[107]|abstract[108]	new[107]|new[108]	_	_
18-13	2177-2184	effects	abstract[107]|abstract[108]	new[107]|new[108]	_	_
18-14	2185-2187	of	abstract[107]|abstract[108]	new[107]|new[108]	_	_
18-15	2188-2199	carotenoids	abstract[107]|abstract[108]|substance	new[107]|new[108]|giv	coref	19-8
18-16	2200-2204	with	_	_	_	_
18-17	2205-2212	special	abstract[110]	new[110]	_	_
18-18	2213-2221	emphasis	abstract[110]	new[110]	_	_
18-19	2222-2224	on	abstract[110]	new[110]	_	_
18-20	2225-2230	liver	abstract[110]|object|abstract[112]	new[110]|new|giv[112]	coref	19-15[117_0]
18-21	2231-2237	health	abstract[110]|abstract[112]	new[110]|giv[112]	_	_
18-22	2238-2239	.	_	_	_	_

#Text=The authors described , e.g. , how carotenoids can interact in patients with non-alcoholic fatty liver disease ( NAFLD ) .
19-1	2240-2243	The	person[113]	giv[113]	coref	21-1[125_113]
19-2	2244-2251	authors	person[113]	giv[113]	_	_
19-3	2252-2261	described	_	_	_	_
19-4	2262-2263	,	_	_	_	_
19-5	2264-2268	e.g.	_	_	_	_
19-6	2269-2270	,	_	_	_	_
19-7	2271-2274	how	_	_	_	_
19-8	2275-2286	carotenoids	substance	giv	coref	24-9
19-9	2287-2290	can	_	_	_	_
19-10	2291-2299	interact	_	_	_	_
19-11	2300-2302	in	_	_	_	_
19-12	2303-2311	patients	person[115]	new[115]	_	_
19-13	2312-2316	with	person[115]	new[115]	_	_
19-14	2317-2330	non-alcoholic	person[115]|abstract[118]	new[115]|new[118]	appos	19-19[0_118]
19-15	2331-2336	fatty	person[115]|abstract|object[117]|abstract[118]	new[115]|new|giv[117]|new[118]	coref|coref	21-5[0_117]|21-18
19-16	2337-2342	liver	person[115]|object[117]|abstract[118]	new[115]|giv[117]|new[118]	_	_
19-17	2343-2350	disease	person[115]|abstract[118]	new[115]|new[118]	_	_
19-18	2351-2352	(	_	_	_	_
19-19	2353-2358	NAFLD	abstract	giv	coref	21-17[133_0]
19-20	2359-2360	)	_	_	_	_
19-21	2361-2362	.	_	_	_	_

#Text=Results of an experiment using Wistar rats are presented by Róvera Costa et al.
20-1	2363-2370	Results	abstract[120]	new[120]	_	_
20-2	2371-2373	of	abstract[120]	new[120]	_	_
20-3	2374-2376	an	abstract[120]|event[121]	new[120]|new[121]	_	_
20-4	2377-2387	experiment	abstract[120]|event[121]	new[120]|new[121]	_	_
20-5	2388-2393	using	abstract[120]|event[121]	new[120]|new[121]	_	_
20-6	2394-2400	Wistar	abstract[120]|event[121]|person|animal[123]	new[120]|new[121]|new|new[123]	_	_
20-7	2401-2405	rats	abstract[120]|event[121]|animal[123]	new[120]|new[121]|new[123]	_	_
20-8	2406-2409	are	_	_	_	_
20-9	2410-2419	presented	_	_	_	_
20-10	2420-2422	by	_	_	_	_
20-11	2423-2429	Róvera	person[124]	new[124]	_	_
20-12	2430-2435	Costa	person[124]	new[124]	_	_
20-13	2436-2438	et	_	_	_	_
20-14	2439-2442	al.	_	_	_	_

#Text=The authors evaluated the liver protective effects of supplementation ( 10 weeks ) with lycopene on non-alcoholic fatty liver disease .
21-1	2443-2446	The	person[125]	giv[125]	coref	27-1[159_125]
21-2	2447-2454	authors	person[125]	giv[125]	_	_
21-3	2455-2464	evaluated	_	_	_	_
21-4	2465-2468	the	abstract[127]	new[127]	_	_
21-5	2469-2474	liver	object|abstract[127]	giv|new[127]	coref	21-19
21-6	2475-2485	protective	abstract[127]	new[127]	_	_
21-7	2486-2493	effects	abstract[127]	new[127]	_	_
21-8	2494-2496	of	abstract[127]	new[127]	_	_
21-9	2497-2512	supplementation	abstract[127]|substance	new[127]|new	_	_
21-10	2513-2514	(	_	_	_	_
21-11	2515-2517	10	time[129]	new[129]	_	_
21-12	2518-2523	weeks	time[129]	new[129]	_	_
21-13	2524-2525	)	_	_	_	_
21-14	2526-2530	with	_	_	_	_
21-15	2531-2539	lycopene	substance[130]	new[130]	coref	28-8[0_130]
21-16	2540-2542	on	substance[130]	new[130]	_	_
21-17	2543-2556	non-alcoholic	substance[130]|abstract[133]	new[130]|giv[133]	_	_
21-18	2557-2562	fatty	substance[130]|abstract|abstract[133]	new[130]|giv|giv[133]	_	_
21-19	2563-2568	liver	substance[130]|object|abstract[133]	new[130]|giv|giv[133]	_	_
21-20	2569-2576	disease	substance[130]|abstract[133]	new[130]|giv[133]	_	_
21-21	2577-2578	.	_	_	_	_

#Text=Chambers et al. synthesized special retinoyl-flavonolignan hybrids and investigated their antioxidant properties .
22-1	2579-2587	Chambers	person	new	_	_
22-2	2588-2590	et	_	_	_	_
22-3	2591-2594	al.	_	_	_	_
22-4	2595-2606	synthesized	_	_	_	_
22-5	2607-2614	special	plant[135]	new[135]	ana	22-10[0_135]
22-6	2615-2637	retinoyl-flavonolignan	plant[135]	new[135]	_	_
22-7	2638-2645	hybrids	plant[135]	new[135]	_	_
22-8	2646-2649	and	_	_	_	_
22-9	2650-2662	investigated	_	_	_	_
22-10	2663-2668	their	plant|abstract[137]	giv|giv[137]	_	_
22-11	2669-2680	antioxidant	abstract[137]	giv[137]	_	_
22-12	2681-2691	properties	abstract[137]	giv[137]	_	_
22-13	2692-2693	.	_	_	_	_

#Text=The paper of Karpiński and Adamczak reports results of antimicrobial activity of the carotenoid fucoxanthin against 20 bacterial species .
23-1	2694-2697	The	abstract[138]	new[138]	_	_
23-2	2698-2703	paper	abstract[138]	new[138]	_	_
23-3	2704-2706	of	abstract[138]	new[138]	_	_
23-4	2707-2716	Karpiński	abstract[138]|person	new[138]|new	_	_
23-5	2717-2720	and	abstract[138]	new[138]	_	_
23-6	2721-2729	Adamczak	abstract[138]|person	new[138]|new	_	_
23-7	2730-2737	reports	_	_	_	_
23-8	2738-2745	results	abstract[141]	new[141]	coref	30-7[180_141]
23-9	2746-2748	of	abstract[141]	new[141]	_	_
23-10	2749-2762	antimicrobial	abstract[141]|abstract[142]	new[141]|giv[142]	coref	28-20[174_142]
23-11	2763-2771	activity	abstract[141]|abstract[142]	new[141]|giv[142]	_	_
23-12	2772-2774	of	abstract[141]|abstract[142]	new[141]|giv[142]	_	_
23-13	2775-2778	the	abstract[141]|abstract[142]|substance[144]	new[141]|giv[142]|new[144]	_	_
23-14	2779-2789	carotenoid	abstract[141]|abstract[142]|object|substance[144]	new[141]|giv[142]|giv|new[144]	coref	27-16
23-15	2790-2801	fucoxanthin	abstract[141]|abstract[142]|substance[144]	new[141]|giv[142]|new[144]	_	_
23-16	2802-2809	against	abstract[141]|abstract[142]	new[141]|giv[142]	_	_
23-17	2810-2812	20	abstract[141]|abstract[142]|animal[145]	new[141]|giv[142]|new[145]	_	_
23-18	2813-2822	bacterial	abstract[141]|abstract[142]|animal[145]	new[141]|giv[142]|new[145]	_	_
23-19	2823-2830	species	abstract[141]|abstract[142]|animal[145]	new[141]|giv[142]|new[145]	_	_
23-20	2831-2832	.	_	_	_	_

#Text=Balić et al. review the photoprotective properties of carotenoids in skin .
24-1	2833-2838	Balić	person	new	_	_
24-2	2839-2841	et	_	_	_	_
24-3	2842-2845	al.	_	_	_	_
24-4	2846-2852	review	_	_	_	_
24-5	2853-2856	the	abstract[147]	new[147]	_	_
24-6	2857-2872	photoprotective	abstract[147]	new[147]	_	_
24-7	2873-2883	properties	abstract[147]	new[147]	_	_
24-8	2884-2886	of	abstract[147]	new[147]	_	_
24-9	2887-2898	carotenoids	abstract[147]|substance	new[147]|giv	coref	25-1[150_0]
24-10	2899-2901	in	abstract[147]	new[147]	_	_
24-11	2902-2906	skin	abstract[147]|object	new[147]|giv	_	_
24-12	2907-2908	.	_	_	_	_

#Text=Dietary carotenoids accumulate in the epidermis and act as a protective barrier to various environmental influences .
25-1	2909-2916	Dietary	substance[150]	giv[150]	coref	30-17[0_150]
25-2	2917-2928	carotenoids	substance[150]	giv[150]	_	_
25-3	2929-2939	accumulate	_	_	_	_
25-4	2940-2942	in	_	_	_	_
25-5	2943-2946	the	place[151]	new[151]	_	_
25-6	2947-2956	epidermis	place[151]	new[151]	_	_
25-7	2957-2960	and	_	_	_	_
25-8	2961-2964	act	_	_	_	_
25-9	2965-2967	as	_	_	_	_
25-10	2968-2969	a	object[152]	new[152]	_	_
25-11	2970-2980	protective	object[152]	new[152]	_	_
25-12	2981-2988	barrier	object[152]	new[152]	_	_
25-13	2989-2991	to	object[152]	new[152]	_	_
25-14	2992-2999	various	object[152]|abstract[153]	new[152]|new[153]	_	_
25-15	3000-3013	environmental	object[152]|abstract[153]	new[152]|new[153]	_	_
25-16	3014-3024	influences	object[152]|abstract[153]	new[152]|new[153]	_	_
25-17	3025-3026	.	_	_	_	_

#Text=In vitro digestion experiments with human milk were done by Xavier et al.
26-1	3027-3029	In	_	_	_	_
26-2	3030-3035	vitro	organization|event[156]	giv|new[156]	_	_
26-3	3036-3045	digestion	abstract|event[156]	new|new[156]	_	_
26-4	3046-3057	experiments	event[156]	new[156]	_	_
26-5	3058-3062	with	event[156]	new[156]	_	_
26-6	3063-3068	human	event[156]|substance[157]	new[156]|new[157]	_	_
26-7	3069-3073	milk	event[156]|substance[157]	new[156]|new[157]	_	_
26-8	3074-3078	were	_	_	_	_
26-9	3079-3083	done	_	_	_	_
26-10	3084-3086	by	_	_	_	_
26-11	3087-3093	Xavier	person	new	_	_
26-12	3094-3096	et	_	_	_	_
26-13	3097-3100	al.	_	_	_	_

#Text=These authors investigated how the lactation stage ( colostrum , mature milk ) affected the carotenoid contents in micelles .
27-1	3101-3106	These	person[159]	giv[159]	_	_
27-2	3107-3114	authors	person[159]	giv[159]	_	_
27-3	3115-3127	investigated	_	_	_	_
27-4	3128-3131	how	_	_	_	_
27-5	3132-3135	the	abstract[161]	giv[161]	_	_
27-6	3136-3145	lactation	object|abstract[161]	new|giv[161]	_	_
27-7	3146-3151	stage	abstract[161]	giv[161]	_	_
27-8	3152-3153	(	_	_	_	_
27-9	3154-3163	colostrum	substance	new	appos	27-11[163_0]
27-10	3164-3165	,	_	_	_	_
27-11	3166-3172	mature	substance[163]	giv[163]	_	_
27-12	3173-3177	milk	substance[163]	giv[163]	_	_
27-13	3178-3179	)	_	_	_	_
27-14	3180-3188	affected	_	_	_	_
27-15	3189-3192	the	substance[165]	giv[165]	_	_
27-16	3193-3203	carotenoid	object|substance[165]	giv|giv[165]	_	_
27-17	3204-3212	contents	substance[165]	giv[165]	_	_
27-18	3213-3215	in	_	_	_	_
27-19	3216-3224	micelles	animal	new	_	_
27-20	3225-3226	.	_	_	_	_

#Text=Wang et al. prepared inclusion complexes of lycopene in β-cyclodextrin and characterized these complexes by looking for stability and antioxidant activity .
28-1	3227-3231	Wang	person	new	_	_
28-2	3232-3234	et	_	_	_	_
28-3	3235-3238	al.	_	_	_	_
28-4	3239-3247	prepared	_	_	_	_
28-5	3248-3257	inclusion	person|object[169]	new|new[169]	coref	28-13[172_169]
28-6	3258-3267	complexes	object[169]	new[169]	_	_
28-7	3268-3270	of	object[169]	new[169]	_	_
28-8	3271-3279	lycopene	object[169]|substance	new[169]|giv	coref	29-1
28-9	3280-3282	in	object[169]	new[169]	_	_
28-10	3283-3297	β-cyclodextrin	object[169]|substance	new[169]|new	coref	29-8
28-11	3298-3301	and	_	_	_	_
28-12	3302-3315	characterized	_	_	_	_
28-13	3316-3321	these	object[172]	giv[172]	_	_
28-14	3322-3331	complexes	object[172]	giv[172]	_	_
28-15	3332-3334	by	_	_	_	_
28-16	3335-3342	looking	_	_	_	_
28-17	3343-3346	for	_	_	_	_
28-18	3347-3356	stability	abstract	new	_	_
28-19	3357-3360	and	_	_	_	_
28-20	3361-3372	antioxidant	abstract[174]	giv[174]	_	_
28-21	3373-3381	activity	abstract[174]	giv[174]	_	_
28-22	3382-3383	.	_	_	_	_

#Text=Lycopene was embedded into the cavity of β-cyclodextrin with a 1:1 stoichiometry .
29-1	3384-3392	Lycopene	substance	giv	_	_
29-2	3393-3396	was	_	_	_	_
29-3	3397-3405	embedded	_	_	_	_
29-4	3406-3410	into	_	_	_	_
29-5	3411-3414	the	place[176]	new[176]	_	_
29-6	3415-3421	cavity	place[176]	new[176]	_	_
29-7	3422-3424	of	place[176]	new[176]	_	_
29-8	3425-3439	β-cyclodextrin	place[176]|substance	new[176]|giv	_	_
29-9	3440-3444	with	_	_	_	_
29-10	3445-3446	a	abstract[178]	new[178]	_	_
29-11	3447-3450	1:1	abstract[178]	new[178]	_	_
29-12	3451-3464	stoichiometry	abstract[178]	new[178]	_	_
29-13	3465-3466	.	_	_	_	_

#Text=Thus , this special issue presents a lot of various results , highlighting preventive effects of carotenoids in diverse conditions .
30-1	3467-3471	Thus	_	_	_	_
30-2	3472-3473	,	_	_	_	_
30-3	3474-3478	this	abstract[179]	new[179]	_	_
30-4	3479-3486	special	abstract[179]	new[179]	_	_
30-5	3487-3492	issue	abstract[179]	new[179]	_	_
30-6	3493-3501	presents	_	_	_	_
30-7	3502-3503	a	abstract[180]	giv[180]	_	_
30-8	3504-3507	lot	abstract[180]	giv[180]	_	_
30-9	3508-3510	of	abstract[180]	giv[180]	_	_
30-10	3511-3518	various	abstract[180]	giv[180]	_	_
30-11	3519-3526	results	abstract[180]	giv[180]	_	_
30-12	3527-3528	,	_	_	_	_
30-13	3529-3541	highlighting	_	_	_	_
30-14	3542-3552	preventive	abstract[181]	new[181]	_	_
30-15	3553-3560	effects	abstract[181]	new[181]	_	_
30-16	3561-3563	of	abstract[181]	new[181]	_	_
30-17	3564-3575	carotenoids	abstract[181]|substance	new[181]|giv	coref	31-7[185_0]
30-18	3576-3578	in	abstract[181]	new[181]	_	_
30-19	3579-3586	diverse	abstract[181]|abstract[183]	new[181]|new[183]	_	_
30-20	3587-3597	conditions	abstract[181]|abstract[183]	new[181]|new[183]	_	_
30-21	3598-3599	.	_	_	_	_

#Text=In addition , some properties of single carotenoids are presented to deepen the knowledge on this fascinating group of compounds .
31-1	3600-3602	In	_	_	_	_
31-2	3603-3611	addition	_	_	_	_
31-3	3612-3613	,	_	_	_	_
31-4	3614-3618	some	abstract[184]	new[184]	_	_
31-5	3619-3629	properties	abstract[184]	new[184]	_	_
31-6	3630-3632	of	abstract[184]	new[184]	_	_
31-7	3633-3639	single	abstract[184]|substance[185]	new[184]|giv[185]	_	_
31-8	3640-3651	carotenoids	abstract[184]|substance[185]	new[184]|giv[185]	_	_
31-9	3652-3655	are	_	_	_	_
31-10	3656-3665	presented	_	_	_	_
31-11	3666-3668	to	_	_	_	_
31-12	3669-3675	deepen	_	_	_	_
31-13	3676-3679	the	abstract[186]	new[186]	_	_
31-14	3680-3689	knowledge	abstract[186]	new[186]	_	_
31-15	3690-3692	on	abstract[186]	new[186]	_	_
31-16	3693-3697	this	abstract[186]|person[187]	new[186]|new[187]	_	_
31-17	3698-3709	fascinating	abstract[186]|person[187]	new[186]|new[187]	_	_
31-18	3710-3715	group	abstract[186]|person[187]	new[186]|new[187]	_	_
31-19	3716-3718	of	abstract[186]|person[187]	new[186]|new[187]	_	_
31-20	3719-3728	compounds	abstract[186]|person[187]|substance	new[186]|new[187]|new	_	_
31-21	3729-3730	.	_	_	_	_
